Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16271099rdf:typepubmed:Citationlld:pubmed
pubmed-article:16271099lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16271099lifeskim:mentionsumls-concept:C0014792lld:lifeskim
pubmed-article:16271099lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:16271099lifeskim:mentionsumls-concept:C2350458lld:lifeskim
pubmed-article:16271099lifeskim:mentionsumls-concept:C0524727lld:lifeskim
pubmed-article:16271099lifeskim:mentionsumls-concept:C0282461lld:lifeskim
pubmed-article:16271099lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:16271099lifeskim:mentionsumls-concept:C0450254lld:lifeskim
pubmed-article:16271099lifeskim:mentionsumls-concept:C2348767lld:lifeskim
pubmed-article:16271099pubmed:issue11lld:pubmed
pubmed-article:16271099pubmed:dateCreated2005-11-7lld:pubmed
pubmed-article:16271099pubmed:abstractTextA randomized, double-blind trial is reported of the clinical efficacy of red blood cells (RBCs) treated for pathogen inactivation with S-303, a synthetic labile alkylating agent.lld:pubmed
pubmed-article:16271099pubmed:languageenglld:pubmed
pubmed-article:16271099pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16271099pubmed:citationSubsetIMlld:pubmed
pubmed-article:16271099pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16271099pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16271099pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16271099pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16271099pubmed:statusMEDLINElld:pubmed
pubmed-article:16271099pubmed:monthNovlld:pubmed
pubmed-article:16271099pubmed:issn0041-1132lld:pubmed
pubmed-article:16271099pubmed:authorpubmed-author:MintzPaul DPDlld:pubmed
pubmed-article:16271099pubmed:authorpubmed-author:BenjaminRicha...lld:pubmed
pubmed-article:16271099pubmed:authorpubmed-author:SpotnitzWilli...lld:pubmed
pubmed-article:16271099pubmed:authorpubmed-author:RizzoRobert...lld:pubmed
pubmed-article:16271099pubmed:authorpubmed-author:McCulloughJef...lld:pubmed
pubmed-article:16271099pubmed:authorpubmed-author:WagesDavidDlld:pubmed
pubmed-article:16271099pubmed:authorpubmed-author:CorashLaurenc...lld:pubmed
pubmed-article:16271099pubmed:authorpubmed-author:SnyderEdwardElld:pubmed
pubmed-article:16271099pubmed:authorpubmed-author:LinJin-SyingJ...lld:pubmed
pubmed-article:16271099pubmed:authorpubmed-author:ConlanMaureen...lld:pubmed
pubmed-article:16271099pubmed:authorpubmed-author:WoodLindseyLlld:pubmed
pubmed-article:16271099pubmed:issnTypePrintlld:pubmed
pubmed-article:16271099pubmed:volume45lld:pubmed
pubmed-article:16271099pubmed:ownerNLMlld:pubmed
pubmed-article:16271099pubmed:authorsCompleteYlld:pubmed
pubmed-article:16271099pubmed:pagination1739-49lld:pubmed
pubmed-article:16271099pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:meshHeadingpubmed-meshheading:16271099...lld:pubmed
pubmed-article:16271099pubmed:year2005lld:pubmed
pubmed-article:16271099pubmed:articleTitleTherapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients.lld:pubmed
pubmed-article:16271099pubmed:affiliationJoint Program in Transfusion Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. benjaminr@usa.redcross.orglld:pubmed
pubmed-article:16271099pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16271099pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:16271099pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16271099pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:16271099pubmed:publicationTypeClinical Trial, Phase IIIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16271099lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16271099lld:pubmed